1. Home
  2. ELMD vs TNXP Comparison

ELMD vs TNXP Comparison

Compare ELMD & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$25.82

Market Cap

208.1M

Sector

Health Care

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$13.25

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELMD
TNXP
Founded
1992
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
198.6M
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
ELMD
TNXP
Price
$25.82
$13.25
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
26.3K
374.6K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
91.75
EPS
0.56
N/A
Revenue
$54,716,000.00
$13,107,000.00
Revenue This Year
$15.59
$558.11
Revenue Next Year
$11.51
$38.29
P/E Ratio
$45.75
N/A
Revenue Growth
13.83
29.85
52 Week Low
$17.73
$11.60
52 Week High
$30.73
$69.65

Technical Indicators

Market Signals
Indicator
ELMD
TNXP
Relative Strength Index (RSI) 55.84 48.38
Support Level $23.29 $11.90
Resistance Level $26.81 $14.52
Average True Range (ATR) 0.84 0.73
MACD -0.00 0.05
Stochastic Oscillator 52.55 47.22

Price Performance

Historical Comparison
ELMD
TNXP

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: